ZANATTA E

Last name: ZANATTA E

2020 (v1)

Publication

Metadata-only

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.

Allanore Y Bozzi S Terlinden A

No description

Uploaded on: April 14, 2023
2022 (v1)

Publication

Metadata-only

Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database.

Iudici M Mongin D Siegert E

No description

Uploaded on: February 4, 2024
2022 (v1)

Publication

Metadata-only

Late Skin Fibrosis in Systemic Sclerosis: A Study from the EUSTAR Cohort.

Hughes M Huang S Alegre-Sancho JJ

No description

Uploaded on: February 14, 2024
2022 (v1)

Publication

Metadata-only

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort.

Zanatta E Huscher D Ortolan A

No description

Uploaded on: February 4, 2024
2018 (v1)

Publication

Metadata-only

Systemic sclerosis: state of the art on clinical practice guidelines

Smith V Scirè CA Talarico R

Systemic sclerosis (SSc) is an orphan disease characterised by autoimmunity, fibrosis of the skin and internal organs, and vasculopathy. SSc may be associated with high morbidity and mortality. In this narrative review we summarise the results of a systematic literature research, which was performed as part of the European Reference Network on...

Uploaded on: March 27, 2023
2022 (v1)

Publication

Metadata-only

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.

Kuster S Jordan S Elhai M

No description

Uploaded on: February 4, 2024

ZANATTA E

Recent uploads